Jiménez-Lucena, R. (author), Camargo, A. (author), Alcalá-Diaz, J.F. (author), Romero-Baldonado, C. (author), Luque, R.M. (author), van Ommen, B. (author), Delgado-Lista, J. (author), Ordovás, J.M. (author), Pérez-Martínez, P. (author), Rangel-Zúñiga, O.A. (author), López-Miranda, J. (author) We aimed to explore whether changes in circulating levels of miRNAs according to type 2 diabetes mellitus (T2DM) or prediabetes status could be used as biomarkers to evaluate the risk of developing the disease. The study included 462 patients without T2DM at baseline from the CORDIOPREV trial. After a median follow-up of 60 months, 107 of the...
article 2018
